论文部分内容阅读
马洛替酯 (ｍａｌｏｔｉｌａｔｅ)是一种治肝病新药 ,用于治疗慢性活动性肝炎及肝硬化已初具疗效[1] 。晚期血吸虫病 (简称晚血 )肝硬化的治疗是血防工作的难点。马洛替酯若能用于治疗或缓解晚血肝硬化 ,将是一个较大突破。基于此 ,设计了以下实验 ,建立动物模型 ,探讨马洛替酯
Mallotilate (malotilate) is a new drug for treating liver disease and has been used to treat chronic active hepatitis and cirrhosis [1]. Advanced schistosomiasis (referred to as late blood) treatment of cirrhosis of the blood is the difficulty of work. Mallotide if used to treat or relieve cirrhosis of the liver will be a bigger breakthrough. Based on this, the following experiments were designed to establish animal models to explore the role of malotilti